000			02179 a2200649 4500
005			20250516213028.0
264		0	_c20141021
008			201410s 0 0 eng d
022			_a2041-4889
024	7		_a10.1038/cddis.2014.186 _2doi
040			_aNLM _beng _cNLM
100	1		_aWang, Y
245	0	0	_aAxl-altered microRNAs regulate tumorigenicity and gefitinib resistance in lung cancer. _h[electronic resource]
260			_bCell death & disease _cMay 2014
300			_ae1227 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAnimals
650	0	4	_aAntineoplastic Agents _xpharmacology
650	0	4	_aApoptosis _xdrug effects
650	0	4	_aCarcinoma, Non-Small-Cell Lung _xdrug therapy
650	0	4	_aCell Cycle Checkpoints _xdrug effects
650	0	4	_aCell Line, Tumor
650	0	4	_aCell Movement _xdrug effects
650	0	4	_aCyclin B1 _xgenetics
650	0	4	_aDisease-Free Survival
650	0	4	_aDose-Response Relationship, Drug
650	0	4	_aDrug Resistance, Neoplasm
650	0	4	_aEpithelial-Mesenchymal Transition _xdrug effects
650	0	4	_aGefitinib
650	0	4	_aHEK293 Cells
650	0	4	_aHumans
650	0	4	_aKaplan-Meier Estimate
650	0	4	_aLung Neoplasms _xdrug therapy
650	0	4	_aMice
650	0	4	_aMice, Nude
650	0	4	_aMicroRNAs _xmetabolism
650	0	4	_aNeoplasm Invasiveness
650	0	4	_aProtein Kinase Inhibitors _xpharmacology
650	0	4	_aProto-Oncogene Proteins _xgenetics
650	0	4	_aQuinazolines _xpharmacology
650	0	4	_aRNA Interference
650	0	4	_aReceptor Protein-Tyrosine Kinases _xmetabolism
650	0	4	_aTime Factors
650	0	4	_aTransfection
650	0	4	_aTumor Burden _xdrug effects
650	0	4	_aWnt Proteins _xgenetics
650	0	4	_aWnt-5a Protein
650	0	4	_aXenograft Model Antitumor Assays
650	0	4	_aAxl Receptor Tyrosine Kinase
700	1		_aXia, H
700	1		_aZhuang, Z
700	1		_aMiao, L
700	1		_aChen, X
700	1		_aCai, H
773	0		_tCell death & disease _gvol. 5 _gp. e1227
856	4	0	_uhttps://doi.org/10.1038/cddis.2014.186 _zAvailable from publisher's website
999			_c23829594 _d23829594